News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
A rigorous journey through Iceland to end myeloma – IMF
Photo from IMF/X
Jul 17, 2024, 04:57

A rigorous journey through Iceland to end myeloma – IMF

International Myeloma Foundation (IMF) shared a post on X:

“Rafat Abonour, hematologist/oncologist, will be the lead cyclist in the inaugural IMF Iceland Cycling Expedition — a rigorous journey through Iceland to end myeloma. Watch the full interview to find out why he’s participating.”  .

Source: IMF/X

cancer end myeloma Hematology ICE IMF IMF Iceland Cycling Expedition International Myeloma Foundation OncoDaily Oncology Rafat Abonour
Blog
Aug 23, 2024, 16:55
Wafik S. El-Deiry: Very informative and interesting discussions at WIN Consortium in Molecular Tumor Board
Blog
Aug 23, 2024, 16:28
Meet the speakers of CityU - AFCR Symposium
Societies
Aug 23, 2024, 16:19
Scalp Cooling workshop by ESMO on September 15 - Cancer Nurse EU
Insight
Aug 23, 2024, 16:19
How ADCs are redefining cancer treatment - Zymeworks Inc.
Blog
Aug 23, 2024, 16:14
Practice changing updates on Metastatic Breast Cancer with Dr. Nan Chen - University of Chicago Hematology
Blog
Aug 23, 2024, 16:10
Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
Opinion
Aug 23, 2024, 16:06
"Coping with Cancer" series by Adrian Pogacian - What is Coping with Cancer?
Blog
Aug 23, 2024, 16:03
The NIH Common Fund wants your ideas - NAEVR
Drugs
Aug 23, 2024, 15:59
Aleix Prat: Our recent article on patritumab deruxtecan is on the list of Nature Communications' Editors’ Highlights
Blog
Aug 23, 2024, 15:52
Last call for WHO’s Model UN Event
Blog
Aug 23, 2024, 15:24
Eugene Woods: Spending time with our Advocate Health administrative fellows
Blog
Aug 23, 2024, 15:13
CDDF and EORTC Multi-Stakeholder Workshop on "Innovation and Access in Rare Cancers"